Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy.
Matthys A, Bardel B, Le Bras F, Créange A, Nordine T, Gounot R, Ingen-Housz-Oro S, Carvalho M, Lefaucheur JP, Haioun C, Planté-Bordeneuve V, Gendre T.
Matthys A, et al. Among authors: bardel b.
Eur J Neurol. 2024 Jul;31(7):e16285. doi: 10.1111/ene.16285. Epub 2024 Mar 21.
Eur J Neurol. 2024.
PMID: 38511878
Free PMC article.